Royal Bank of Canada’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
CFM
VP
VCM
MA
BFM
Royal Bank of Canada's MXCT Position: Q1 2026 in Review
Royal Bank of Canada reduced its MaxCyte (MXCT) stake by 72% in Q1 2026, selling an estimated $3.07K and leaving 1,299 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #6912.
Royal Bank of Canada first reported a position in MXCT in Q3 2021 and has held it in 19 quarters since. The position peaked at $209K in Q4 2021. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.
- Royal Bank of Canada held 1,299 shares of MaxCyte worth $1K as of Q1 2026.
- Royal Bank of Canada sold 3,287 MaxCyte shares in Q1 2026, an estimated $3.07K.
- MaxCyte made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6912 holding.
- Royal Bank of Canada first reported a position in MaxCyte in Q3 2021 and has held it in 19 quarters since.
- Royal Bank of Canada's MaxCyte position peaked at $209K in Q4 2021.
- 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.